Michael A. Sweetland

2.4k citations
16 papers · 2.1k indexed · 1 hit paper · h-index 15

Michael A. Sweetland

16 papers receiving 2.0k citations

Hit Papers

Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formati...19922026200320141992100200300400500

Peers

Michael A. Sweetland
Comparison fields: 5 of 106
  • Physiology 897
  • Surgery 716
  • Endocrinology, Diabetes and Metabolism 495
  • Molecular Biology 444
  • Genetics 425
Replace Vasilij Koshkin with:
Vasilij Koshkin Canada
Katarzyna A. Broniowska United States
Frederick G. Hamel United States
K D Kröncke Germany
Steven E. Mayer United States
Lydie Plecitá‐Hlavatá Czechia
William H. Baricos United States
Klaus‐Dietrich Kröncke Germany
Lawrence J. Wardzala United States
Carina Prip‐Buus France
Michael A. Sweetland relative to Vasilij Koshkin Canada Vasilij Koshkin's profile →
Citations per field
00.5×1.7×
Vasilij Koshkin · 1×
Citations per year

Countries citing papers authored by Michael A. Sweetland

Since Specialization
Citations

This map shows the geographic impact of Michael A. Sweetland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Sweetland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Sweetland more than expected).

Fields of papers citing papers by Michael A. Sweetland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Sweetland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Sweetland. The network helps show where Michael A. Sweetland may publish in the future.

Co-authorship network of co-authors of Michael A. Sweetland

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Sweetland. A scholar is included among the top collaborators of Michael A. Sweetland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Sweetland. Michael A. Sweetland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 51
2 17
3 30
4 23
5 32
6
Nitric oxide generation following intrahepatic human-to-rat islet transplantation is blocked by NG-monomethyl-L-arginine.
2
7 95
8 76
9 63
10 353
11 254
12 129
13
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunctionbreakdown →
526
14 151
15 232
16 19

About Michael A. Sweetland

Michael A. Sweetland is a scholar working on Biophysics, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 16 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (7 papers), Pancreatic function and diabetes (7 papers) and Diet, Metabolism, and Disease (6 papers). The work is most often cited by research in Biochemistry (272 citations), Physiology (897 citations) and Endocrinology, Diabetes and Metabolism (495 citations). Michael A. Sweetland has collaborated with scholars based in United States. Frequent co-authors include Jack R. Lancaster, John A. Corbett, Michael L. McDaniel, Jaw‐Lin Wang, Joseph R. Williamson, Yasuo Ido, Ronald G. Tilton, Kathy Chang, Khalid S. Hasan and Mauricio Di Silvio. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026